NOV 17, 2020 5:00 AM PST

Utilizing rapid diagnostics and new methods to quickly diagnose sepsis

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Laboratory Manager Microbiology and Virology
    Biography
      Francis Yongblah is the Laboratory Manager and In-Service Trainee Consultant Clinical Scientist, in the Microbiology and Virology department at Great Ormond Street Hospital (GOSH), London, UK. Francis has worked as a Healthcare Scientist for over 10 years and has a wealth of knowledge and experience in Microbiology. In addition to running and managing the service at GOSH, Francis is heavily involved in research to improve patient outcomes, within the department at GOSH, as well forming collaborations with UCL and other NHS laboratories. Francis is part of the team working on precision AMR which is an exciting project working to utilize rapid diagnostics to improve antibiotic prescribing and working towards preventing the threat of Antimicrobial Resistance (AMR). Part of this project will be focusing on the improved use of MALDI Biotyper® and utilizing it to improve patient outcomes.

    Abstract
    Date: November 17, 2020
    Time: 5:00am (PST), 8:00am (EST), 2:00pm (CET)
     
    Septicemia is a serious clinical condition with roundabout 123,000 cases of sepsis a year in England. In recent years there have been great advances in improving time to identification of pathogens causing sepsis. One of the key methods is the Bruker MBT Sepsityper® IVD Kit which can be used together with the MALDI Biotyper® for fast identification of causative pathogens from Positive Blood Cultures. This presentation looks at the clinical benefits of using the Bruker Sepsityper® solution to improve patient treatment and management. Although the Sepsityper® method has improved diagnosis, the initially introduced full extraction workflow could be further improved in terms of user intervention and reduced time to result. This investigation/presentation also looks at a validation of the new Rapid Sepsityper® workflow, which leads to a much shortened sample preparation procedure for identification of isolates from blood culture bottles, further reducing the time to diagnosis.
     
    Learning Objectives
    • Improving the identification of pathogens by the MALDI Biotyper®
    • Using the MBT Sepsityper® IVD Kit for rapid identification of pathogens from Positive Blood Cultures
    • Validation of the Rapid Sepsityper® Workflow

     

    Please contact your local representative for availability in your country. Not for sale in the USA.

     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more